Approvals/TGA/TACROLIMUS XR SANDOZ tacrolimus (as monohydrate) 0.5 mg prolonged-release capsule blister pack

Approved

STANDARD

TACROLIMUS XR SANDOZ tacrolimus (as monohydrate) 0.5 mg prolonged-release capsule blister pack

Sandoz Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 75bdf59c668a17ec
Product Name: TACROLIMUS XR SANDOZ tacrolimus (as monohydrate) 0.5 mg prolonged-release capsule blister pack
Artg Id: 366770
Artg Name: TACROLIMUS XR SANDOZ tacrolimus (as monohydrate) 0.5 mg prolonged-release capsule blister pack
Sponsor: Sandoz Pty Ltd
Company Detail Path: /organization/sandoz-pty-ltd
Artg Date: 2022-08-05
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2024-CMI-01771-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2022-PI-01833-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

75bdf59c668a17ec

Type

Standard